Do you want to read an article? Please log in or register.
Metered-Dose Liquid Nitrogen Cryospray for Chronic Bronchitis: Results From the Prospective, Sham-Controlled Trial (SPRAY-CB)
COPD
Related content
COMMENTED
Bronchi
Metered cryospray in patients with chronic bronchitis: a mechanistic randomised controlled study
★ 3
Recommended and commented by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Thorax
Orton CM, Tonkin J, Chan LT, Tana A, Marc ST, Conway F, Baikov AN, Wawman R, Eastwood M, Vijayakumar B, Thornton J, D'Sa L, Hartman JE, Klooster K, Slebos DJ, Robertus JL, Bhavsar PK, Shah PL
doi: 10.1136/thorax-2026-224822
COMMENTED
COPD
Summary of Research: Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trials (the ENHANCE Trials)
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Adv Ther
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Rickard K, O'Donovan K, Sciurba F
doi: 10.1007/s12325-026-03514-6
COMMENTED
COPDBronchi
Efficacy and Safety of Broncho Muco Cleaner Balloon Dilation Therapy in Chronic Bronchitis-Predominant COPD: A Prospective Interventional Study
★ 3
Recommended and commented by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Çetinkaya E, Çörtük M, Turan D, İlhan U, Karaahmetoğlu FS, Özcan ZB, Demirkol B
doi: 10.3390/jcm15145607
RECOMMENDED
AsthmaRespiratory Tract Infection
Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir Rev
Kyriakopoulos C, Ntritsos G, Gogali A, Papanikolaou A, Angelopoulos V, Oikonomou ED, Kostikas K
doi: 10.1183/16000617.0186-2025
COPD
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease
Eur Respir J
Saralaya D, Mustapa MN, Ferreira J, Kocks JWH, Brailsford W, Rosengren S, Spata E, Belvisi MG, Leander J, Riff C, De Palo G, Windgassen D, Chalmers JD, Russell REK, Hurst JR, Śmiałowski A, Hughes R
doi: 10.1183/13993003.02567-2025
Asthma
Time to Rethink ICS Dosing in Pursuit of Asthma Clinical Remission: High-Dose ICS/LABA May Restore Short-Term Asthma Control When Medium Doses Fail
J Clin Med
Kołacińska-Flont M, Kupryś-Lipińska I, Wojakiewicz M, Dębowski T, Kuna P
doi: 10.3390/jcm15145462
COPDPneumonia
Extracorporeal CO(2) elimination for acute exacerbation of severe COPD requiring invasive mechanical ventilation: a randomized controlled trial (the X-COPD trial)
Crit Care
Karagiannidis C, Riera J, Blanco-Schweizer P, Strassmann S, Merten M, Brodie D, Staudinger T, Windisch W, Brochard L, Slutsky AS
doi: 10.1186/s13054-026-06300-6
Pulmonary Fibrosis
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Am J Respir Crit Care Med
Nathan SD, Smith P, Deng C, Golden J, Reynaud-Gaubert M, Farr G, Bregman B, Crossno PF, Harari S, Gupta N, Jouneau S, Adir Y, Molina-Molina M, Breytenbach N, Peterson L, Bell H, Zywot E, Rao Y, Flaherty KR, Cottin V, Behr J, TETON-1 and TETON-2 Trial Investigators
doi: 10.1093/ajrccm/aamag507
ARDSPneumonia
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
Lancet Respir Med
Leslie K, Darvall JN, Chan MTV, Peyton PJ, Myles PS, Corcoran TB, Short TG, Olesnicky BL, Webb AR, Devlin N, Tran-Duy A, Maxwell-Wright H, Schultz-Ferguson C, Fitzpatrick P, Sidiropoulos S, Braat S, Story DA, SNaPP Study Investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network
doi: 10.1016/S2213-2600(26)00158-X